Opthea Limited (OPT.AX)
AUD 0.66
(1.54%)
AUD 0.66
(1.54%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -199.28 Million USD | 10.75% |
| 2023 | -223.29 Million USD | -67.69% |
| 2022 | -133.16 Million USD | -151.08% |
| 2021 | -52.84 Million USD | -114.91% |
| 2020 | -24.91 Million AUD | 32.64% |
| 2019 | -36.63 Million AUD | -22.61% |
| 2018 | -29.73 Million AUD | -202.76% |
| 2017 | -9.79 Million AUD | -22.54% |
| 2016 | -7.71 Million AUD | -15.5% |
| 2015 | -8.08 Million AUD | -11.47% |
| 2014 | -6.81 Million AUD | 13.39% |
| 2013 | -6.53 Million AUD | 19.01% |
| 2012 | -7.44 Million AUD | 20.34% |
| 2011 | -11.04 Million AUD | -10.08% |
| 2010 | -9.62 Million AUD | -34.29% |
| 2009 | -9.23 Million AUD | 40.01% |
| 2008 | -8.21 Million AUD | 66.66% |
| 2007 | -37.87 Million AUD | -869.35% |
| 2006 | -4.4 Million AUD | -122.16% |
| 2005 | 21.88 Million AUD | 1088.53% |
| 2004 | -2.54 Million AUD | 39.36% |
| 2003 | -2.94 Million AUD | 8.54% |
| 2002 | -3.21 Million AUD | -298.42% |
| 2001 | -807.29 Thousand AUD | -51.08% |
| 2000 | -534.33 Thousand AUD | -100.02% |
| 1999 | 2.93 Billion AUD | 1524699.67% |
| 1998 | 192.73 Thousand AUD | -19.86% |
| 1997 | 240.51 Thousand AUD | 124.87% |
| 1996 | -967.05 Thousand AUD | -85.26% |
| 1995 | -521.99 Thousand AUD | -561.46% |
| 1994 | -78.91 Thousand AUD | 77.32% |
| 1993 | -348.02 Thousand AUD | -380.31% |
| 1992 | -72.45 Thousand AUD | 55.64% |
| 1991 | -163.34 Thousand AUD | 73.96% |
| 1990 | -627.41 Thousand AUD | -22.57% |
| 1989 | -511.89 Thousand AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -143.8 Million USD | 0.0% |
| 2024 FY | - USD | 15.83% |
| 2023 FY | - USD | -67.69% |
| 2023 Q2 | -117.87 Million USD | 0.0% |
| 2023 Q4 | -105.55 Million USD | 0.0% |
| 2022 Q2 | -53.86 Million USD | 0.0% |
| 2022 Q4 | -82.83 Million USD | 0.0% |
| 2022 FY | - USD | -151.08% |
| 2021 FY | - USD | -114.91% |
| 2021 Q2 | -26.37 Million USD | 0.0% |
| 2020 Q4 | -13.11 Million AUD | 0.0% |
| 2020 FY | - AUD | 32.64% |
| 2020 Q2 | -11.56 Million AUD | 0.0% |
| 2019 Q2 | -19.79 Million AUD | 0.0% |
| 2019 Q4 | -17.11 Million AUD | 0.0% |
| 2019 FY | - AUD | -22.61% |
| 2018 Q4 | -16.47 Million AUD | 0.0% |
| 2018 FY | - AUD | -202.76% |
| 2017 FY | - AUD | -22.54% |
| 2017 Q4 | - AUD | 0.0% |
| 2016 FY | - AUD | -15.5% |
| 2016 Q4 | - AUD | 0.0% |
| 2015 FY | - AUD | -11.47% |
| 2015 Q4 | - AUD | 0.0% |
| 2014 Q4 | - AUD | 0.0% |
| 2014 FY | - AUD | 13.39% |
| 2013 Q1 | -1.8 Million AUD | 0.0% |
| 2013 Q3 | -1.57 Million AUD | 0.0% |
| 2013 Q2 | -1.57 Million AUD | 12.83% |
| 2013 FY | - AUD | 19.01% |
| 2013 Q4 | - AUD | 100.0% |
| 2012 Q2 | -1.8 Million AUD | 34.54% |
| 2012 FY | - AUD | 20.34% |
| 2012 Q1 | -2.75 Million AUD | 0.0% |
| 2012 Q4 | - AUD | 100.0% |
| 2012 Q3 | -1.8 Million AUD | 0.0% |
| 2011 Q4 | - AUD | 100.0% |
| 2011 FY | - AUD | -10.08% |
| 2011 Q3 | -2.75 Million AUD | 0.0% |
| 2011 Q2 | -2.75 Million AUD | -61.75% |
| 2011 Q1 | -1.7 Million AUD | 0.0% |
| 2010 Q4 | - AUD | 100.0% |
| 2010 Q3 | -1.7 Million AUD | 0.0% |
| 2010 Q1 | -2.45 Million AUD | 0.0% |
| 2010 Q2 | -1.7 Million AUD | 30.77% |
| 2010 FY | - AUD | -34.29% |
| 2009 Q4 | - AUD | 100.0% |
| 2009 FY | - AUD | 40.01% |
| 2009 Q3 | -2.45 Million AUD | 0.0% |
| 2009 Q2 | -2.45 Million AUD | -18738.61% |
| 2009 Q1 | 13.19 Thousand AUD | 0.0% |
| 2008 Q4 | - AUD | -100.0% |
| 2008 Q3 | 13.19 Thousand AUD | 0.0% |
| 2008 Q2 | 13.19 Thousand AUD | -99.69% |
| 2008 Q1 | 4.23 Million AUD | 0.0% |
| 2008 FY | - AUD | 66.66% |
| 2007 Q4 | - AUD | -100.0% |
| 2007 FY | - AUD | -869.35% |
| 2007 Q1 | -1.5 Million AUD | 0.0% |
| 2007 Q2 | 4.23 Million AUD | 380.44% |
| 2007 Q3 | 4.23 Million AUD | 0.0% |
| 2006 Q3 | -1.5 Million AUD | 0.0% |
| 2006 FY | - AUD | -122.16% |
| 2006 Q1 | 5.5 Million AUD | 0.0% |
| 2006 Q4 | - AUD | 100.0% |
| 2006 Q2 | -1.5 Million AUD | -127.38% |
| 2005 FY | - AUD | 1088.53% |
| 2005 Q1 | 2.9 Million AUD | 0.0% |
| 2005 Q2 | 5.5 Million AUD | 89.91% |
| 2005 Q3 | 5.5 Million AUD | 0.0% |
| 2005 Q4 | - AUD | -100.0% |
| 2004 Q3 | 2.9 Million AUD | 0.0% |
| 2004 FY | - AUD | 39.36% |
| 2004 Q4 | - AUD | -100.0% |
| 2004 Q2 | 2.9 Million AUD | 262.59% |
| 2004 Q1 | -1.78 Million AUD | 0.0% |
| 2003 Q2 | -1.78 Million AUD | 37.69% |
| 2003 Q3 | -1.78 Million AUD | 0.0% |
| 2003 Q4 | - AUD | 100.0% |
| 2003 FY | - AUD | 8.54% |
| 2003 Q1 | -2.86 Million AUD | 0.0% |
| 2002 Q2 | -2.86 Million AUD | -637.0% |
| 2002 Q4 | - AUD | 100.0% |
| 2002 Q3 | -2.86 Million AUD | 0.0% |
| 2002 FY | - AUD | -298.42% |
| 2002 Q1 | -388.6 Thousand AUD | 0.0% |
| 2001 FY | - AUD | -51.08% |
| 2001 Q2 | -388.6 Thousand AUD | -163.53% |
| 2001 Q1 | 611.68 Thousand AUD | 0.0% |
| 2001 Q4 | - AUD | 100.0% |
| 2001 Q3 | -388.6 Thousand AUD | 0.0% |
| 2000 Q2 | 611.68 Thousand AUD | -48.39% |
| 2000 Q1 | 1.18 Million AUD | 0.0% |
| 2000 FY | - AUD | -100.02% |
| 2000 Q4 | - AUD | -100.0% |
| 2000 Q3 | 611.68 Thousand AUD | 0.0% |
| 1999 Q4 | - AUD | -100.0% |
| 1999 FY | - AUD | 1524699.67% |
| 1999 Q3 | 1.18 Million AUD | 0.0% |
| 1999 Q2 | 1.18 Million AUD | 339.3% |
| 1999 Q1 | -495.25 Thousand AUD | 0.0% |
| 1998 Q1 | -349.52 Thousand AUD | 0.0% |
| 1998 Q2 | -495.25 Thousand AUD | -41.69% |
| 1998 Q4 | -495.25 Thousand AUD | 0.0% |
| 1998 Q3 | -495.25 Thousand AUD | 0.0% |
| 1998 FY | - AUD | -19.86% |
| 1997 FY | - AUD | 124.87% |
| 1997 Q4 | - AUD | 100.0% |
| 1997 Q2 | -349.52 Thousand AUD | -28.5% |
| 1997 Q3 | -349.52 Thousand AUD | 0.0% |
| 1997 Q1 | -272 Thousand AUD | 0.0% |
| 1996 Q2 | -272 Thousand AUD | -64.1% |
| 1996 Q4 | -272 Thousand AUD | 0.0% |
| 1996 FY | - AUD | -85.26% |
| 1996 Q1 | -165.75 Thousand AUD | 0.0% |
| 1996 Q3 | -272 Thousand AUD | 0.0% |
| 1995 FY | - AUD | -561.46% |
| 1995 Q3 | -165.75 Thousand AUD | 0.0% |
| 1995 Q4 | -165.75 Thousand AUD | 0.0% |
| 1995 Q2 | -165.75 Thousand AUD | -1005.0% |
| 1995 Q1 | -15 Thousand AUD | 0.0% |
| 1994 Q2 | -15 Thousand AUD | 88.24% |
| 1994 FY | - AUD | 77.32% |
| 1994 Q1 | -127.5 Thousand AUD | 0.0% |
| 1994 Q3 | -15 Thousand AUD | 0.0% |
| 1994 Q4 | -15 Thousand AUD | 0.0% |
| 1993 Q2 | -127.5 Thousand AUD | -553.85% |
| 1993 Q1 | -19.5 Thousand AUD | 0.0% |
| 1993 FY | - AUD | -380.31% |
| 1993 Q4 | -127.5 Thousand AUD | 0.0% |
| 1993 Q3 | -127.5 Thousand AUD | 0.0% |
| 1992 Q2 | -19.5 Thousand AUD | 55.17% |
| 1992 Q4 | -19.5 Thousand AUD | 0.0% |
| 1992 FY | - AUD | 55.64% |
| 1992 Q1 | -43.5 Thousand AUD | 0.0% |
| 1992 Q3 | -19.5 Thousand AUD | 0.0% |
| 1991 Q3 | -43.5 Thousand AUD | 0.0% |
| 1991 FY | - AUD | 73.96% |
| 1991 Q1 | -154 Thousand AUD | 0.0% |
| 1991 Q2 | -43.5 Thousand AUD | 71.75% |
| 1991 Q4 | -43.5 Thousand AUD | 0.0% |
| 1990 FY | - AUD | -22.57% |
| 1990 Q1 | -133.5 Thousand AUD | 0.0% |
| 1990 Q3 | -154 Thousand AUD | 0.0% |
| 1990 Q2 | -154 Thousand AUD | -15.36% |
| 1990 Q4 | -154 Thousand AUD | 0.0% |
| 1989 Q4 | -133.5 Thousand AUD | 0.0% |
| 1989 FY | - AUD | 0.0% |
| 1989 Q2 | -133.5 Thousand AUD | 0.0% |
| 1989 Q3 | -133.5 Thousand AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 10.37 Million AUD | 2020.764% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -13581.14% |
| Zelira Therapeutics Limited | -36.44 Million AUD | -446.876% |
| Biome Australia Limited | -1.57 Million AUD | -12527.157% |
| Patrys Limited | -3.49 Million AUD | -5606.744% |
| Orthocell Limited | -11.68 Million AUD | -1606.071% |
| Imugene Limited | -147.97 Million AUD | -34.675% |
| Noxopharm Limited | -5.94 Million AUD | -3251.923% |
| PYC Therapeutics Limited | -38.11 Million AUD | -422.825% |
| Chimeric Therapeutics Limited | -11.29 Million AUD | -1663.647% |
| Prescient Therapeutics Limited | -7.18 Million AUD | -2673.4% |
| Proteomics International Laboratories Limited | -7.88 Million AUD | -2426.69% |
| Cynata Therapeutics Limited | -9.95 Million AUD | -1902.856% |
| CSL Limited | 4.73 Billion AUD | 104.211% |
| Arovella Therapeutics Limited | -8.83 Million AUD | -2156.137% |
| Bio-Gene Technology Limited | -2.97 Million AUD | -6598.791% |
| Clinuvel Pharmaceuticals Limited | 51.86 Million AUD | 484.26% |
| Starpharma Holdings Limited | -12.57 Million AUD | -1484.545% |
| Nanollose Limited | -1.14 Million AUD | -17261.099% |
| Memphasys Limited | -3.3 Million AUD | -5924.941% |
| Invex Therapeutics Ltd | -720.44 Thousand AUD | -27561.978% |
| NeuroScientific Biopharmaceuticals Limited | -1.79 Million AUD | -10994.466% |
| Amplia Therapeutics Limited | -4.55 Million AUD | -4270.742% |
| Botanix Pharmaceuticals Limited | -13.91 Million AUD | -1331.733% |
| Island Pharmaceuticals Limited | -2.81 Million AUD | -6971.681% |
| Race Oncology Limited | -14.2 Million AUD | -1303.105% |
| Nyrada Inc. | -4.59 Million AUD | -4235.933% |
| Telix Pharmaceuticals Limited | 22.96 Million AUD | 967.753% |
| Dimerix Limited | -24.95 Million AUD | -698.477% |
| PharmAust Limited | -9.45 Million AUD | -2008.487% |
| Immutep Limited | -42.87 Million AUD | -364.81% |
| Clarity Pharmaceuticals Ltd | -44.64 Million AUD | -346.358% |
| Alterity Therapeutics Limited | -19.57 Million AUD | -918.252% |
| BTC Health Limited | 1.05 Million AUD | 18984.743% |
| Acrux Limited | -7.93 Million AUD | -2412.776% |
| Neuren Pharmaceuticals Limited | 199.26 Million AUD | 200.013% |
| Biotron Limited | -5.04 Million AUD | -3854.089% |
| Tissue Repair Ltd | -5.77 Million AUD | -3350.881% |
| AdAlta Limited | -5.3 Million AUD | -3658.24% |
| Radiopharm Theranostics Limited | -45.37 Million AUD | -339.191% |
| Hexima Limited | -995.54 Thousand AUD | -19918.044% |
| AnteoTech Limited | -11.57 Million AUD | -1622.313% |
| Paradigm Biopharmaceuticals Limited | -64.53 Million AUD | -208.786% |
| Recce Pharmaceuticals Ltd | -21.35 Million AUD | -833.255% |
| Avecho Biotechnology Limited | -3.24 Million AUD | -6046.11% |
| Actinogen Medical Limited | -12.92 Million AUD | -1442.339% |
| Immuron Limited | -6.19 Million AUD | -3118.294% |
| Argenica Therapeutics Limited | -1.89 Million AUD | -10402.17% |